PUBLISHER: IMARC | PRODUCT CODE: 1518752
PUBLISHER: IMARC | PRODUCT CODE: 1518752
Japan Diabetes Market Report: 2024-2032
The Japan diabetes market size reached US$ 5.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 7.3 Billion by 2032, exhibiting a growth rate (CAGR) of 3.3% during 2024-2032.
Diabetes refers to a chronic disease in which the ability of a human body to produce and respond to insulin hormone becomes impaired. This results in abnormal metabolism of carbohydrates and elevated levels of glucose in the blood. In Japan, a large section of the population is over 60 years, an age when type-2 diabetes becomes more prevalent. Moreover, as the Japanese diet consists of a significant portion of refined carbohydrates, like white rice and noodles, it puts the population at a higher risk of developing and aggravating diabetes.
Japan Diabetes Market Drivers:
With the growing influence of western cuisines, increasing working hours and declining domestic agricultural production, consumers are now relying on processed food products and fast-food like burger, taco, hotdog and pizza. As these food products are high in carbohydrates, sodium and preservatives, their rising consumption has increased the cases of diabetes in the country. The other factors that are contributing to the increasing cases of diabetes include growing obese population and sedentary lifestyles. However, to minimize the prevalence of diabetes in the country, the Government of Japan is undertaking several initiatives. For instance, it is offering health insurance to both the citizens and non-citizens residing for more than a year in Japan through their universal health care system.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the Japan diabetes market report, along with forecasts for the period 2024-2032. Our report has categorized the market based on segment.
Breakup by Segment:
Oral Antidiabetics
Insulin
Currently, insulin represents the dominant segment, accounting for the majority of the total market share. Insulin in Japan is usually taken through pens, pumps, syringes and jet injectors as they offer convenience to the patients. Increasing diagnostic rates and awareness among patients are enabling them to incorporate insulin therapy for treating diabetes.
Competitive Landscape:
The competitive landscape of the market has been analyzed in the report with detailed profiles of key players operative in the industry.
Key Questions Answered in This Report:
- How has the Japan diabetes market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the Japan diabetes market?
- Which are the popular segments in the Japan diabetes market?
- What are the various stages in the value chain of the Japan diabetes market?
- What are the key driving factors and challenges in the Japan diabetes market?
- What is the structure of the Japan diabetes market and who are the key players?
- What is the degree of competition in the Japan diabetes market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Diabetes Disease Overview
- 5.1 What is Diabetes?
- 5.2 Diabetes Diagnosis and Treatment
- 5.2.1 Diagnosis
- 5.2.2 Treatment
- 5.3 Diabetes Complications
6 Japan Diabetes Epidemiology
- 6.1 Diabetes Population and Prevalence Rates
- 6.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
- 6.3 Population and Prevalence Rates by Region
- 6.4 Population and Prevalence Rates by Gender
- 6.5 Population and Prevalence Rates by Age Group
7 Japan Diabetes Market
- 7.1 Market Overview
- 7.2 Market Performance
- 7.3 Impact of COVID-19
- 7.4 Market Forecast
- 7.5 SWOT Analysis
- 7.5.1 Overview
- 7.5.2 Strengths
- 7.5.3 Weaknesses
- 7.5.4 Opportunities
- 7.5.5 Threats
- 7.6 Value Chain Analysis
- 7.7 Porter's Five Forces Analysis
- 7.7.1 Overview
- 7.7.2 Bargaining Power of Buyers
- 7.7.3 Bargaining Power of Suppliers
- 7.7.4 Degree of Competition
- 7.7.5 Threat of New Entrants
- 7.7.6 Threat of Substitutes
- 7.8 Market Breakup by Segment
- 7.8.1 Japan Oral Antidiabetics Market
- 7.8.1.1 Historical Market Trends
- 7.8.1.2 Market Breakup by Class
- 7.8.1.3 Market Shares of Key Players
- 7.8.1.4 Market Forecast
- 7.8.2 Japan Insulin Market
- 7.8.2.1 Historical Market Trends
- 7.8.2.2 Market Breakup by Class
- 7.8.2.3 Market Shares of Key Players
- 7.8.2.4 Market Forecast
- 7.8.1 Japan Oral Antidiabetics Market
8 Competitive Landscape
- 8.1 Market Structure
- 8.2 Profiles of Key Players
List of Figures
- Figure 1: The Impact of Diabetes in the Human Body
- Figure 2: Diabetes Complications
- Figure 3: Global: Breakup of Diabetes Patients by Region, (in %) 2023 & 2032
- Figure 4: Body Mass Index and Relative risk of Type-2 Diabetes
- Figure 5: Japan: Total Number of Diabetes Patients (in 000), 2018-2023
- Figure 6: Japan: Total Number of Diabetes Patients Forecast (in 000), 2024-2032
- Figure 7: Japan (Type1 & Type2): Total Number of Diabetes Patients (in 000), 2018-2023
- Figure 8: Japan (Type1 & Type2): Total Number of Diabetes Patients Forecast (in 000), 2024-2032
- Figure 9: Japan (Urban & Rural): Total Number of Diabetes Patients (in 000), 2018-2023
- Figure 10: Japan (Urban & Rural): Total Number of Diabetes Patients Forecast (in 000), 2024-2032
- Figure 11: Japan (Male & Female): Total Number of Diabetes Patients (in 000), 2018-2023
- Figure 12: Japan (Male & Female): Total Number of Diabetes Patients Forecast (in 000), 2024-2032
- Figure 13: Japan: Total Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (in 000), 2018-2023
- Figure 14: Japan: Total Number of Diabetes Patients Forecast by Age Group (20-39), (40-59) & (60-79) (in 000), 2024-2032
- Figure 15: Japan: Diabetes Drug Industry Overview
- Figure 16: Japan: Diabetes Drug Market: Sales Value (in Billion US$), 2018-2023
- Figure 17: Japan: Diabetes Drug Market Forecast: Sales Value (in Billion US$), 2024-2032
- Figure 18: Japan: Diabetes Drug Market: SWOT Analysis
- Figure 19: Japan: Diabetes Drug Market: Value Chain Analysis
- Figure 20: Japan: Diabetes Drug Market: Porters Five Forces Analysis
- Figure 21: Japan: Diabetes Drug Market: Breakup of Insulin and Oral Antidiabetics (in %), 2018-2023
- Figure 22: Japan: Diabetes Drug Market Forecast: Breakup of Insulin and Oral Antidiabetics (in %), 2024-2032
- Figure 23: Japan: Oral Antidiabetics Market: Sales Value (in Million US$), 2018-2023
- Figure 24: Japan: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2018 & 2023
- Figure 25: Japan: Oral Anti-diabetics Market: Sales Share of Key Players (in %)
- Figure 26: Japan: Oral Antidiabetics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 27: Japan: Insulin Market: Sales Value (in Million US$), 2018-2023
- Figure 28: Japan: Breakup of Insulin Market by Class (in %), 2023
- Figure 29: Japan: Insulin Market: Sales Share of Key Players (in %)
- Figure 30: Japan: Insulin Market Forecast: Sales Value (in Million US$), 2024-2032
List of Tables
- Table 1: Diagnosis of Diabetes
- Table 2: Global: Diabetes Population Breakup by Country (in 000's), 2023 and 2032
- Table 3: Japan: Total Prevalence & Number of Diabetes Patients, 2018, 2023 & 2032
- Table 4: Japan (Type1 & Type2): Total Prevalence & Number of Diabetes Patients, 2018, 2023 & 2032
- Table 5: Japan (Urban & Rural): Total Prevalence & Number of Diabetes Patients, 2018, 2023 & 2032
- Table 6: Japan (Male & Female): Total Prevalence & Number of Diabetes Patients, 2018, 2023 & 2032
- Table 7: Japan: Total Prevalence & Number of Diabetes Patients by Age Group (20-39, 40-59, 60-79 - In Millions), 2018, 2023 & 2032
- Table 8: Japan: Diabetes Drug Market: Competitive Structure
